IFN-γ signaling plays an integral role in regulating immune activation and senescence in the TME, induces the expression of PD-L1 and is an essential component of an effective anti-tumor response with PD-1 pathway targeted agents14,15. The gene discussed is IFNG; the disease is neoplasm.